US Soccer Ditches Crypto Funding, Hires Pochettino with Citadel Backing

Paradigm Leads $9M Round in El Dorado, a Stablecoin Payments App for Latin America

Strive CIO Ben Werkman Warns Bitcoin Firms Over Convertible Debt Risks

Bitmine Raises $274M in Preferred Stock Sale, Adds $136M in Ether

Bitcoin

Colombia is one of Latin America's top crypto‑adoption markets, with high usage for remittances and savings amidst peso devaluation and banking exclusion. The election pits a leftist candidate (Gustavo Petro) against a right‑wing populist (Rodolfo Hernández); a Petro win could bring tighter capital controls and ambiguous crypto rules, while a Hernández win might sustain a more laissez‑faire environment. This event fits into a pattern of political uncertainty in emerging markets that often accelerates peer‑to‑peer crypto usage, but does not move major crypto indices beyond noise.

Colombia prepares for presidential election amidst resurgence of political violence, with a focus on conflict reporting by a student journalist.

Colombia votes Sunday amid violence; student journalist's death exposes crypto funding gap for war reporters

Colombian journalist's death reveals $2 billion on-chain funding gap for independent war reporters – a quiet catalyst for decentralized media tokens

While xenotransplantation solves a critical organ shortage, it is a biotech narrative that does not intersect with crypto fundamentals. Any capital rotation from speculative assets into biotech would be negligible given current market caps.

First successful transplantation of pig liver and kidneys into a human, using genetically modified pig organs in trials in China and the US.

Pig Organ Transplant Success Validates DeSci Funding Models, Tokenized Biotech on Horizon

Pig organ transplants validate DeSci funding models, paving the way for tokenized biotech IPOs

Kraken Launches Prop Trading Platform, Lets Users Trade With Up to $200K in Capital

Cerebras Systems Lifts IPO Range as Oversubscription Signals AI's Grip on Venture Capital

The article reflects a growing global push for public-private partnerships in healthcare, which could divert government attention and fiscal resources away from crypto-friendly policies. However, any macroeconomic effects are highly indirect and years away, making this irrelevant for near-term crypto trends.

Nature published an article on 13 May 2026 titled 'Economic reform can save antibiotic innovation' calling for government incentives to stimulate antibiotic development.

Nature's Antibiotic Incentive Call Points to Broken Drug R&D — Crypto-Funded Science Sees Opening

Nature's call for antibiotic incentives is a bullish signal for DeSci tokens as traditional pharma R&D model cracks

Gency AI Secures $20 Million to Build Sovereign AI‑Powered Advertising Network

Cluster Protocol Secures $5 Million Funding to Fast‑Track CodeXero AI IDE

The move away from traditional public grants dovetails with the rise of tokenized philanthropy, DeSci platforms, and crypto‑funded grant programs that have raised >$1.2 bn in 2025. This aligns with a broader macro trend of investors seeking alternative, uncensorable capital flows amid a fearful market environment.

Nature published an article on 22 April 2026 discussing how scientific philanthropies are expanding their reach amid shifting public funding.

Nature Publishes Study on Rise of Scientific Philanthropies Amid Declining Public Funding

Scientific philanthropies could become the next wave of high‑trust crypto custodians, injecting institutional BTC demand and tightening market liquidity

This move dovetails with the broader trend of de‑regulation in high‑risk innovation spaces (e.g., crypto, AI, gene‑editing). As Washington shows willingness to accelerate research pipelines, investors may extrapolate that similar regulatory momentum could eventually benefit crypto projects that position themselves as “science‑first” or health‑oriented. The policy also reinforces the narrative that the US is a global hub for frontier‑tech financing.

A US executive order was issued to streamline investigations of psychedelic drugs, including ibogaine.